These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 8587686

  • 1. Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.
    Williams PC, Henner WD, Roman-Goldstein S, Dahlborg SA, Brummett RE, Tableman M, Dana BW, Neuwelt EA.
    Neurosurgery; 1995 Jul; 37(1):17-27; discussion 27-8. PubMed ID: 8587686
    [Abstract] [Full Text] [Related]

  • 2. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA, Petrillo A, Crossen JR, Roman-Goldstein S, Doolittle ND, Fuller KH, Neuwelt EA.
    Cancer J Sci Am; 1998 Jul; 4(2):110-24. PubMed ID: 9532413
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors.
    Castello MA, Clerico A, Deb G, Dominici C, Fidani P, Donfrancesco A.
    Am J Pediatr Hematol Oncol; 1990 Jul; 12(3):297-300. PubMed ID: 2173440
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ.
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [Abstract] [Full Text] [Related]

  • 7. Preirradiation ifosfamide, carboplatin, and etoposide for the treatment of anaplastic astrocytomas and glioblastoma multiforme: a phase II study.
    López-Aguilar E, Sepúlveda-Vildósola AC, Rivera-Márquez H, Cerecedo-Díaz F, Hernández-Contreras I, Ramón-García G, Diegopérez-Ramírez J, Santacruz-Castillo E.
    Arch Med Res; 2000 Mar; 31(2):186-90. PubMed ID: 10880725
    [Abstract] [Full Text] [Related]

  • 8. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K, Kanaya H, Fujiyama Y, Kim P.
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term toxicity and neuropathology associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery.
    Remsen LG, McCormick CI, Sexton G, Pearse HD, Garcia R, Mass M, Roman-Goldstein S, Neuwelt EA.
    Neurosurgery; 1997 May; 40(5):1034-40; discussion 1040-2. PubMed ID: 9149262
    [Abstract] [Full Text] [Related]

  • 11. Neoadjuvant chemotherapy for brain tumors in infants and young children.
    Iwama J, Ogiwara H, Kiyotani C, Terashima K, Matsuoka K, Iwafuchi H, Morota N.
    J Neurosurg Pediatr; 2015 May; 15(5):488-92. PubMed ID: 25723725
    [Abstract] [Full Text] [Related]

  • 12. Treatment of recurrent malignant supratentorial astrocytomas with carboplatin and etoposide combined with recombinant mutant human tumor necrosis factor-alpha.
    Yamamoto M, Oshiro S, Tsugu H, Hirakawa K, Ikeda K, Soma G, Fukushima T.
    Anticancer Res; 2002 May; 22(4):2447-53. PubMed ID: 12174942
    [Abstract] [Full Text] [Related]

  • 13. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
    Margolin K, Doroshow JH, Ahn C, Hamasaki V, Leong L, Morgan R, Raschko J, Shibata S, Somlo G, Tetef M.
    J Clin Oncol; 1996 Oct; 14(10):2631-7. PubMed ID: 8874321
    [Abstract] [Full Text] [Related]

  • 14. Chemotherapy for brain tumors.
    Pech IV, Peterson K, Cairncross JG.
    Oncology (Williston Park); 1998 Apr; 12(4):537-43, 547; discussion 547-8, 553. PubMed ID: 9575527
    [Abstract] [Full Text] [Related]

  • 15. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
    Fleischhack G, Pöpping K, Hasan C, Utsch B, Jüttner J, Bode U.
    Klin Padiatr; 1998 Apr; 210(4):248-55. PubMed ID: 9743961
    [Abstract] [Full Text] [Related]

  • 16. Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption.
    Neuwelt EA, Gilmer-Knight K, Lacy C, Nicholson HS, Kraemer DF, Doolittle ND, Hornig GW, Muldoon LL.
    Pediatr Blood Cancer; 2006 Aug; 47(2):174-82. PubMed ID: 16086410
    [Abstract] [Full Text] [Related]

  • 17. Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.
    da Silva NS, Cappellano AM, Diez B, Cavalheiro S, Gardner S, Wisoff J, Kellie S, Parker R, Garvin J, Finlay J.
    Pediatr Blood Cancer; 2010 Mar; 54(3):377-83. PubMed ID: 20063410
    [Abstract] [Full Text] [Related]

  • 18. Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.
    Jahnke K, Kraemer DF, Knight KR, Fortin D, Bell S, Doolittle ND, Muldoon LL, Neuwelt EA.
    Cancer; 2008 Feb 01; 112(3):581-8. PubMed ID: 18072268
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.